L
Laurence L. Greenhill
Researcher at Columbia University
Publications - 111
Citations - 15523
Laurence L. Greenhill is an academic researcher from Columbia University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Poison control. The author has an hindex of 58, co-authored 111 publications receiving 14055 citations.
Papers
More filters
Journal ArticleDOI
The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner,Gregory K. Brown,Barbara Stanley,David A. Brent,Kseniya V. Yershova,Maria A. Oquendo,Glenn W. Currier,Glenn A. Melvin,Laurence L. Greenhill,Sa Shen,J. John Mann +10 more
TL;DR: Findings suggest that the Columbia-Suicide Severity Rating Scale is suitable for assessment of suicidal ideation and behavior in clinical and research settings.
Journal ArticleDOI
Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.
Ronald C. Kessler,Lenard A. Adler,Russell A. Barkley,Joseph Biederman,C. Keith Conners,Stephen V. Faraone,Laurence L. Greenhill,Savina Jaeger,Kristina Secnik,Thomas J. Spencer,T. Bedirhan Üstün,Alan M. Zaslavsky +11 more
TL;DR: A retrospective assessment of childhood ADHD, childhood risk factors, and a screen for adult ADHD were included in a sample of 3197 18-44 year old respondents in the National Comorbidity Survey Replication (NCS-R).
Journal ArticleDOI
3-Year Follow-up of the NIMH MTA Study
Peter S. Jensen,L. Eugene Arnold,James M. Swanson,Benedetto Vitiello,Howard Abikoff,Laurence L. Greenhill,Lily Hechtman,Lily Hechtman,Stephen P. Hinshaw,William E. Pelham,Karen C. Wells,C. Keith Conners,Glen R. Elliott,Jeffery N. Epstein,Betsy Hoza,John S. March,Brooke S. G. Molina,Jeffrey H. Newcorn,Jeffrey H. Newcorn,Joanne B. Severe,Timothy Wigal,Robert D. Gibbons,Kwan Hur +22 more
TL;DR: By 36 months, the earlier advantage of having had 14 months of the medication algorithm was no longer apparent, possibly due to age-related decline in ADHD symptoms, changes in medication management intensity, starting or stopping medications altogether, or other factors not yet evaluated.
Journal ArticleDOI
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers.
Peter S. Jensen,Stephen P. Hinshaw,James M. Swanson,Laurence L. Greenhill,C. Conners,L. Arnold,Howard Abikoff,Glen R. Elliott,Lily Hechtman,Betsy Hoza,John S. March,Jeffrey H. Newcorn,Joanne B. Severe,Benedetto Vitiello,Karen C. Wells,Timothy Wigal +15 more
TL;DR: Primary analyses revealed that Comb had a significant incremental effect over MedMgt (with a small effect size for this comparison) when categorical indicators of excellent response and when composite outcome measures were used.
Journal ArticleDOI
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
John T. Walkup,Michael J. Labellarte,Mark A. Riddle,Daniel S. Pine,Daniel S. Pine,Laurence L. Greenhill,Rachel G. Klein,Mark Davies,Michael Sweeney,Howard Abikoff,Sabine Hack,Brian Klee,James T. McCracken,Lindsey Bergman,John Piacentini,John S. March,Scott N. Compton,James A. Robinson,Thomas O’hara,Sherryl Baker,Benedetto Vitiello,Louise Ritz,Margaret Roper +22 more
TL;DR: Fuvoxamine is an effective treatment for children and adolescents with social phobia, separation anxiety disorder, or generalized anxiety disorder and reduces symptoms of anxiety on the Pediatric Anxiety Rating Scale.